From receptor biology to therapy: importance of different EGFR mutations in the development of targeted cancer therapies.
- DOI
- 10.1080/1750743x.2026.2728525
- Published
- 2026 Sep 15
- Container
- Immunotherapy
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/1750743x.2026.2728525,
title = {From receptor biology to therapy: importance of different EGFR mutations in the development of targeted cancer therapies.},
author = {Krishnaja U and J N and Sarkar M and Menon KN and Kalita B},
year = {2026},
journal = {Immunotherapy},
doi = {10.1080/1750743x.2026.2728525},
url = {https://doi.org/10.1080/1750743x.2026.2728525}
}RIS
TY - JOUR TI - From receptor biology to therapy: importance of different EGFR mutations in the development of targeted cancer therapies. AU - Krishnaja U AU - J N AU - Sarkar M AU - Menon KN AU - Kalita B PY - 2026 JO - Immunotherapy DO - 10.1080/1750743x.2026.2728525 UR - https://doi.org/10.1080/1750743x.2026.2728525 ER -
APA
U, K., N, J., M, S., KN, M., & B, K. (2026). From receptor biology to therapy: importance of different EGFR mutations in the development of targeted cancer therapies.. Immunotherapy. https://doi.org/10.1080/1750743x.2026.2728525
Source records
- pubmed · retrieved 2026-09-26T07:20:15.554Z